[
  {
    "ts": null,
    "headline": "Amgen Inc. stock rises Thursday, still underperforms market",
    "summary": "Amgen Inc. stock rises Thursday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=fcd044ac73fc11aad3a4b597e64a7736a4cd2f5b87b0d579ce35a12d93039adb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730997480,
      "headline": "Amgen Inc. stock rises Thursday, still underperforms market",
      "id": 131192189,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen Inc. stock rises Thursday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=fcd044ac73fc11aad3a4b597e64a7736a4cd2f5b87b0d579ce35a12d93039adb"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Insiders Sold US$4.0m Of Shares Suggesting Hesitancy",
    "summary": "In the last year, many Amgen Inc. ( NASDAQ:AMGN ) insiders sold a substantial stake in the company which may have...",
    "url": "https://finnhub.io/api/news?id=555a01a336b7e3fa606d913bfda58f0e129e8c4c418138378763375ad143ac38",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730984464,
      "headline": "Amgen Insiders Sold US$4.0m Of Shares Suggesting Hesitancy",
      "id": 131178842,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/7137ef364be97d9882cfa4ec57169a99",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "In the last year, many Amgen Inc. ( NASDAQ:AMGN ) insiders sold a substantial stake in the company which may have...",
      "url": "https://finnhub.io/api/news?id=555a01a336b7e3fa606d913bfda58f0e129e8c4c418138378763375ad143ac38"
    }
  },
  {
    "ts": null,
    "headline": "FDA Accepts ABLAs For Prolia® / Xgeva® Biosimilars From Organon And Teva",
    "summary": "On October 30, 2024, Organon announced the FDA acceptance of its aBLA for HLX14, a proposed biosimilar of Amgen's Prolia® / Xgeva® . Organon licensed the commercialization rights for HLX14 in the...",
    "url": "https://finnhub.io/api/news?id=35b6e6657179b58f685241c038121aa1971ea4d93f511225341896680046b53e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730970673,
      "headline": "FDA Accepts ABLAs For Prolia® / Xgeva® Biosimilars From Organon And Teva",
      "id": 131154684,
      "image": "",
      "related": "AMGN",
      "source": "Finnhub",
      "summary": "On October 30, 2024, Organon announced the FDA acceptance of its aBLA for HLX14, a proposed biosimilar of Amgen's Prolia® / Xgeva® . Organon licensed the commercialization rights for HLX14 in the...",
      "url": "https://finnhub.io/api/news?id=35b6e6657179b58f685241c038121aa1971ea4d93f511225341896680046b53e"
    }
  }
]